216 related articles for article (PubMed ID: 18378278)
1. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome.
Brito-Zerón P; Soria N; Muñoz S; Bové A; Akasbi M; Belenguer R; Sisó A; Ramos-Casals M
Semin Arthritis Rheum; 2009 Apr; 38(5):389-95. PubMed ID: 18378278
[TBL] [Abstract][Full Text] [Related]
2. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
4. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
5. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
Friedman J; Schattner A; Shvidel L; Berrebi A
Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
[TBL] [Abstract][Full Text] [Related]
6. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
7. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
Ramos-Casals M; Sánchez-Tapias JM; Parés A; Forns X; Brito-Zerón P; Nardi N; Vazquez P; Vélez D; Arias I; Bové A; Plaza J; Rodés J; Font J
J Rheumatol; 2006 Aug; 33(8):1593-9. PubMed ID: 16881116
[TBL] [Abstract][Full Text] [Related]
8. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
10. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.
Martens PB; Pillemer SR; Jacobsson LT; O'Fallon WM; Matteson EL
J Rheumatol; 1999 Jun; 26(6):1296-300. PubMed ID: 10381046
[TBL] [Abstract][Full Text] [Related]
11. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
Theander E; Manthorpe R; Jacobsson LT
Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients.
Marcos M; Alvarez F; Brito-Zerón P; Bove A; Perez-De-Lis M; Diaz-Lagares C; Sanchez-Tapias JM; Ramos-Casals M
Autoimmun Rev; 2009 Jun; 8(7):616-20. PubMed ID: 19393197
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients.
Pérez-De-Lis M; Akasbi M; Sisó A; Diez-Cascon P; Brito-Zerón P; Diaz-Lagares C; Ortiz J; Perez-Alvarez R; Ramos-Casals M; Coca A
Lupus; 2010 Jul; 19(8):941-8. PubMed ID: 20581017
[TBL] [Abstract][Full Text] [Related]
14. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of 43 patients with Sjögren's syndrome].
Cui G; Sugai S; Ogawa Y; Takeshita S; Masaki Y; Fukutoku M
Ryumachi; 1997 Dec; 37(6):770-80. PubMed ID: 9492564
[TBL] [Abstract][Full Text] [Related]
17. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
Tishler M; Yaron I; Shirazi I; Yaron M
J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
[TBL] [Abstract][Full Text] [Related]
19. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
